RE: To all24 Jan 2018 23:40
I believe futura is just ? More than a gamble at this present time, the reason being is if the csd500 condom gets fully launched in all the countries planned, then eventually the royalties could be a considerable amount of money, there's the USA and CHINA to sell to. Even as a possible niche product with a long 18 month shelf life and patent to 2038, we have a valuable asset here, yes it takes years to penetrate and build up global sales , but that will definitely happen.
It's the lack of promoting the condom that slows down penetrating every individual market , as that cost tens of millions in every currency.
That will take time, but we will eventually earn millions in royalties, it's not if ..., it's just when.
Then we have the whole pain portfolio , that will bring in good stead royalties if the right companies promote it and sell it ,,,,,,, as our pain medications are as good if not better than what's already out there,
But to gain any traction in this field or promote our pain medications name ,,,will also cost huge sums of money, ,,,,,,,,,but there's definitely plenty of money to be made across our pain portfolio,,,,,,, and especially
As the medical profession is turning or requesting. More and more pain or any medications to be administered in a non oral way, as the systemic side effects from oral medication can be much more damaging to our system ,,,liver etc,,,, so any new skin penetrating pain medication is welcomed and needed to address this much needed market,,,,,,,, and our pain portfolio just fits this market perfectly,,,,,,,,,,,,,resulting in some substantial royalties...........
The MED202 eroxon gel seems to be according to the futura medical board our most valuable asset...
And this has been there view for very many years,,,,,,,
All there completely independent research models to sell this product have confirmed this opinion,,,
And the phase 2 trial ,,,100% confirms this MED GEL works the best for this medical need,, and most importantly the active ingredient has a 100 year safety profile treating angina,,,,,,,,,,
This product is going to sell extremely well in my opinion ,,,as there is a substantial unmet market and limited
medications to treat people with.......never mind it just being a fun product to use.......
So I ask myself adding all these products and royalties together should easily even with every product becoming a unlikely niche product pulling In enough royalties to more that justify the current valuation.
And at best substantially increasing our royalties to tens of �millions� justifyingtify a valuation many times the current price........
This is why I don't see futura as a outright gamble.......I see it as a very good bussiness proposition.......with a clear trajectory to make substantial amounts of money for the company and us it's shareholders...
This is only my opinion and nobody should just buy on the strengths of on